IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 50 filers reported holding IMMUNOCORE HLDGS PLC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,819,452 | -51.4% | 53,687 | -6.8% | 0.01% | -42.9% |
| Q1 2024 | $3,745,950 | +192.8% | 57,630 | +207.7% | 0.02% | +162.5% |
| Q4 2023 | $1,279,497 | -62.4% | 18,728 | -71.5% | 0.01% | -68.0% |
| Q3 2023 | $3,406,457 | -1.9% | 65,635 | +13.3% | 0.02% | +8.7% |
| Q2 2023 | $3,473,903 | +228.0% | 57,937 | +170.5% | 0.02% | +283.3% |
| Q1 2023 | $1,059,054 | -77.9% | 21,421 | -74.5% | 0.01% | -78.6% |
| Q4 2022 | $4,792,910 | +101.5% | 83,983 | +65.7% | 0.03% | +115.4% |
| Q3 2022 | $2,379,000 | +51.8% | 50,688 | +20.7% | 0.01% | +30.0% |
| Q2 2022 | $1,567,000 | +7361.9% | 42,009 | +6006.0% | 0.01% | – |
| Q1 2022 | $21,000 | +10.5% | 688 | +37.6% | 0.00% | – |
| Q3 2021 | $19,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $34,592,303 | 27.53% |
| RTW INVESTMENTS, LP | 6,029,633 | $361,536,795 | 6.88% |
| Paradigm Biocapital Advisors LP | 1,270,124 | $76,156,635 | 5.88% |
| Rock Springs Capital Management LP | 3,028,410 | $181,583,464 | 4.32% |
| Logos Global Management LP | 500,000 | $29,980,000 | 4.08% |
| TANG CAPITAL MANAGEMENT LLC | 405,600 | $24,319,776 | 3.58% |
| GREAT POINT PARTNERS LLC | 297,082 | $17,813,037 | 3.49% |
| Eschler Asset Management LLP | 34,000 | $2,038,640 | 2.89% |
| COWEN AND COMPANY, LLC | 460,036 | $27,583,758 | 2.29% |
| HighVista Strategies LLC | 44,094 | $2,643,876 | 1.21% |